Autologous Bone Marrow Mononuclear Cell Therapy is Safe and Promotes Amputation Free Survival in Patients with Critical Limb Ischemia

OBJECTIVE: The purpose of this phase I open label non-randomized trial was to assess the safety and efficacy of autologous bone marrow mononuclear cell (ABMNC) therapy in promoting amputation free survival (AFS) in patients with critical limb ischemia (CLI). METHODS: Between September 2005 and March...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Murphy, Michael P., Lawson, Jeffrey H., Rapp, Brian M., Dalsing, Michael C., Klein, Janet, Wilson, Michael G., Hutchins, Gary D., March, Keith L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3102148/
https://ncbi.nlm.nih.gov/pubmed/21514773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvs.2011.01.074
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia